SCHEMBL7333321

SCHEMBL7333321

NCC(=O)CNc1cccc2c1CCCC2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.56
RXRA P19793 1/20 0.54
RXRB P28702 1/20 0.54
RXRG P48443 1/20 0.54
HDAC6 Q9UBN7 2/20 0.53
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
LMNA P02545 3/20 0.51
THRA P10827 1/20 0.51
THRB P10828 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.49
HTT P42858 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
KDM4E B2RXH2 2/20 0.47
POLB P06746 1/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
TSHR P16473 2/20 0.46
GRIN2D O15399 1/20 0.45
GRIN3B O60391 1/20 0.45
GRIN1 Q05586 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4573751 0.82 RXRA (0.57) ALDH1A1RXRARXRBRXRGHDAC6
SCHEMBL28669599 0.82 ALDH1A1 (0.54) ALDH1A1RXRARXRBRXRGHDAC6
SCHEMBL7326556 0.82 ALDH1A1 (0.56) ALDH1A1RXRARXRBRXRGHDAC6
SCHEMBL7331010 0.79 RXRA (0.60) ALDH1A1RXRARXRBRXRGHDAC6
SCHEMBL7335957 0.78 LMNA (0.67) ALDH1A1RXRARXRBRXRGHDAC6
SCHEMBL13256427 0.73 ALDH1A1 (0.61) ALDH1A1RXRARXRBRXRGHDAC6
SCHEMBL4573756 0.73 HTT (0.51) ALDH1A1RXRARXRBRXRGHDAC6
SCHEMBL2357753 0.73 ALDH1A1 (0.63) ALDH1A1RXRARXRBRXRGMEN1
SCHEMBL11935623 0.73 HTT (0.51) ALDH1A1RXRARXRBRXRGHDAC6
SCHEMBL8166642 0.73 HTT (0.58) ALDH1A1RXRARXRBRXRGHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5196454-A METHOD OF TREATING DISORDERS OF THE DOPAMINERGIC SYSTEMS USING 2,5-DIAMINOTETRALINES BOEHRINGER INGELHEIM KG (DE) 1993-03-23 US disclosed
EP-0402923-A2 2,5-Diaminotetralines, process for their preparation and their use as medicine BOEHRINGER INGELHEIM KG (DE) 1990-12-19 EP disclosed